Back
American Express Vs. Akero Therapeutics Industry Stock Comparison
Buy
66
AXP
American Express
Last Price:
$315.68
Seasonality Move:
-0.92%
Sell
46
AKRO
Akero Therapeutics
Last Price:
$54.35
Seasonality Move:
25.71%
Buy
66
American Express (AXP)
is a Buy
Is American Express a Buy, Sell or Hold?
-
The current American Express [AXP] share price is $315.35. The Score for AXP is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
AXP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $54.33. The Score for AKRO is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
AKRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AXP Stock Price Chart
What is American Express's stock price today?
-
The American Express share price today is $315.35Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AXP is experiencing slight buying pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $54.33Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight buying pressure.
AXP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.91 | Buy |
Relative Strength Index (14 RSI): | 54.54 | Buy |
Chaikin Money Flow: | 1581442 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (299.2 - 322.24) | Buy |
Bollinger Bands (100): | (261.73 - 307.41) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.51 | Buy |
Relative Strength Index (14 RSI): | 58.59 | Buy |
Chaikin Money Flow: | 300279 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (51.7 - 55.12) | Buy |
Bollinger Bands (100): | (40.15 - 52.23) | Buy |
AXP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 317.23 | Sell |
20-day SMA: | 314.8 | Buy |
50-day SMA: | 302.14 | Buy |
200-day SMA: | 289.76 | Buy |
8-day EMA: | 316.33 | Sell |
20-day EMA: | 313.53 | Buy |
50-day EMA: | 302.83 | Buy |
200-day EMA: | 283.11 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 52.19 | Buy |
20-day SMA: | 53.1 | Buy |
50-day SMA: | 49.83 | Buy |
200-day SMA: | 39.72 | Buy |
8-day EMA: | 52.8 | Buy |
20-day EMA: | 52.55 | Buy |
50-day EMA: | 50.28 | Buy |
200-day EMA: | 41.46 | Buy |
American Express Earnings Growth & AXP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.77 per share, an increase next quarter of $0.41 per share, an increase this year of $1.67 per share, and an increase next year of $2.08 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.
American Express Technical Analysis
Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |